Urothelial Cancer | Specialty

The OncLive Urology condition center page is a comprehensive resource for clinical news and expert insights on urologic cancers, including prostate cancer, bladder cancer, testicular cancer, penile cancer, and renal cell carcinoma. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in brain cancer.

Investigating Large and Small Urology Practice Intricacies

August 10th 2012

Balancing Quality of Care and Costs in Urology Practices

August 10th 2012

Physician Extenders in Urology Practices, Part I

August 10th 2012

Bone Health Programs in Urology Practices, Part II

August 10th 2012

Introduction to Urologists in Cancer Care Peer Exchange

August 10th 2012

Bone Health Programs in Urology Practices, Part I

August 10th 2012

Management of Oncology Care in Urology Practices

August 10th 2012

Physician Extenders in Urology Practices, Part II

August 10th 2012

The Importance of Correct Coding in Specialty-Focused Cancer Treatment Centers

May 15th 2012

When you consider how complex the system is, and how little training physicians get in medical school about coding, it stands to reason that practice leadership must emphasize its importance.

A Word of Welcome

May 14th 2012

It is with great pleasure that I welcome you to the inaugural issue of Urologists in Cancer Care.

Treatment Guidelines for High-Grade Bladder Cancer Are Usually Ignored

November 16th 2011

Investigators have documented gross under-use of established recommendations for the management of high-grade noninvasive bladder cancer.

Expanding the Scope of Cystoscopy: Imaging Agent Illuminates More Lesions

October 11th 2011

An interview with Neal D. Shore, MD, discussing expanding the scope of cystoscopy and the optical imaging agent Cysview.

Patients With Bladder Cancer Not Getting Recommended Care

July 14th 2011

Study results reveal that only a small fraction of patients with high-grade, noninvasive bladder cancer receive the appropriate treatment.

Dr. Cella Discusses Axitinib and Sorafenib Axis Trial

June 17th 2011

Dr. Cella From Northwestern University Feinberg School of Medicine Discusses Axitinib and Sorafenib Axis Trial

Prolonged Use of Diabetes Drug Actos May Increase Risk of Bladder Cancer

June 16th 2011

The FDA announced that the prolonged use of pioglitazone (Actos) for more than 1 year has been linked to an increased risk of bladder cancer

Dr. Alter Discusses Research at JTCC

March 14th 2011

Dr. Robert Alter on Current Research at John Theurer Cancer Center

Dr. Alter on Kidney Cancer Drugs From 2005-2010

March 14th 2011

Robert S. Alter, MD, Co-chief, Urologic Oncology, John Theurer Cancer Center, on kidney cancer drugs from the year 2005 to 2010.

Flash Findings

August 17th 2010

Fast biotech facts and figures. In this issue: 1) Cancer Risk Factors and Mortality 2) Bladder Cancer 3) Testicular Cancer 4) Breast Cancer

Updated Guidelines on Non-Muscle Invasive Bladder Cancer

June 24th 2010

Each year, more than 60,000 people are diagnosed with bladder cancer, which has been linked to a number of risk factors, including cigarette smoking and exposure to hazardous chemicals.

Staying Focused in Turbulent Times

May 24th 2010

When the market is volatile, people think about their financial future. With current market events as turbulent as they are, you may be concerned about their potential impact on your 401(k) account. During times like this, it is more important than ever to follow certain basic, time-tested principles of investing.